Establishing non-inferiority in treatment trials in psychiatry — guidelines from an Expert Consensus Meeting

Abstract

Comparing the efficacy of different treatments in psychiatry is difficult for many reasons, even when they are investigated in `head-to-head' studies. A consensus meeting was, therefore, held to produce best practice guidelines for such studies. This article presents the conclusions of this consensus and illustrates it using published data in the field of antidepressant treatment of generalized anxiety disorder.

Keywords

clinical trials duloxetine GAD non-inferiority venlafaxine

Get full access to this article

View all access options for this article.

References

Allgulander, C , Hackett, D , Salinas, E (2001) Venlafaxine extended release (ER) in the treatment of generalized anxiety disorder. Br J Psychiatry 179: 15-22.

Argyropoulos, SV , Ploubidis, GB , Wright, TS , Palm, ME , Hood, SD , Nash, JR , Taylor, AC , Forshall, SW , Anderson, IM , Nutt, DJ , Potokar, JP (2007) Development and validation of the Generalized Anxiety Disorder Inventory (GADI). J Psychopharmacol 21: 145- 152.

CHMP Guideline on the Clinical investigation of medicinal products indicated for Generalised Anxiety Disorder CPMP/EWP/4284/02. Published January 2005 Effective July 2005. Access at http://www.emea.europa.eu/htms/human/humanguidelines/efficacy.htm

CHMP Points to Consider on the Choice of Non-inferiority Margin. CPMP/EWP/2158/99. Published Jul 2005. Effective Jan 2006. Access at http://www.emea.europa.eu/htms/human/humanguidelines/efficacy.htm

CHMP Points to Consider on Switching Between Superiority and Non-inferiority. CPMP/EWP/482/99. Published July 2000. Effective February 2001. Access at http://www.emea.europa.eu/htms/human/humanguidelines/efficacy.htm

Davidson, JRT , Bose, A , Su, G (2002a, b) Escitalopram in the treatment of generalized anxiety disorder. Poster presented at the 42nd Annual New Clinical Drug Evaluation (NCDEU) Meeting. Boca Raton, FL, USA, 10-13 June 2002.

Davidson, JR , Bose, A , Korotzer, A , Zheng, H (2004) Escitalopram in the treatment of generalized anxiety disorder: a double-blind, placebo-controlled, flexible dose study. Depress Anxiety 19: 234-240.

Davidson, JR , DuPont, RL , Hedges, D , Haskins, JT (1999) Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatient with GAD. J Clin Psychiatry 60: 528-535.

Gelenberg, AJ , Lydiard, RB , Rudolph, RL , Aguiar, L , Haskins, JT , Salinas, E (2000) Efficacy of venlafaxine extended release in nondepressed outpatients with generalized anxiety disorder: a 6 month randomized controlled trial. JAMA 283: 3082-3088.

10.

Goodman, WK , Bose, A , Wang, Q (2003) Escitalopram 10 mg/day is effective in the treatment of generalized anxiety disorder. Poster presented at: 23rd Annual Conference of the Anxiety Disorders Association of America ; March 27-30, 2003; Toronto, Canada.

11.

Gotzsche, PC (2006) Noninferiority and equivalence randomized trials: lessons and reservations-secondary publication. Ugeskr Laeger 168: 3137-3139.

12.

Hung, HMJ , Wang, SJ , Tsong, Y , Lawrence, J , O'Neil, RT (2003) Some fundamental issues with non-inferiority testing in active controlled trials. Statist Med 22: 213-225.

13.

ICH Note for Guidance E9 (Statistical Principles for Clinical Trials). Adopted by CPMP, March 1998, issued as CPMP/ICH/363/96. Access at http://www.ich.org/cache/compo/475-272-1.html

14.

ICH Note for Guidance E10 (Choice of Control Group). Adopted by CPMP, July 2000, issued as CPMP/ICH/364/96. Access at http://www.ich.org/cache/compo/475-272-1.html

15.

Lenox-Smith, AJ , Reynolds, A (2003) A double-blind, randomized, placebo-controlled study of venlafaxine XL in patients with generalized anxiety disorder in primary care. Br J Gen Pract 53: 772- 777.

16.

Pollack, MH , Zaninelli, R , Goddard, A , McCafferty, JP , Bellew, KM , Burnham, DB , Iyengar, MK (2001) Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible dosage trial. J Clin Psychol 62: 350-357.

17.

Prescrire International Paroxetine in generalized anxiety: uncertain efficacy . Prescrire Int 2003; 12: 175-177.

18.

Rickels, K , Pollack, MH , Sheehan, DV , Haskins, JT (2000) Efficacy of extended-release venlafaxine in nondepressed outpatients with GAD. Am J Psychiatry 157: 968-974.

19.

Rickels, K , Zaninelli, R , McCafferty, J , Bellew, K , Iyengar, M , Sheehan, D (2003) Paroxetine treatment of generalized anxiety disorder: a double-blind, placebo controlled study. Am J Psychiatry 160: 749-756.